The human pituitary nitroproteome: detection of nitrotyrosyl-proteins with two-dimensional Western blotting, and amino acid sequence determination with mass spectrometry.

Nitric oxide is an important mediator that participates in reduction-oxidation (redox) mechanisms and in cellular signal transduction pathways. Two types of post-translational modifications are induced by nitric oxide: S-nitrosylation of cysteine residues and nitration of tyrosine residues. Two-dimensional gel electrophoresis-based Western blotting was used to detect, and liquid chromatography (LC)-tandem mass spectrometry (MS/MS) to determine the amino acid sequence of, several different nitrated proteins in the human pituitary. Proteins from several 2D gel spots, which corresponded to the strongly positive anti-nitrotyrosine Western blot spots, were subjected to in-gel trypsin-digestion and LC-MS/MS analysis. MS/MS, SEQUEST analysis, and de novo sequencing were used to determine the nitration site of each nitrated peptide. A total of four different nitrated peptides were characterized and were matched to four different proteins: synaptosomal-associated protein, actin, immunoglobulin alpha Fc receptor, and cGMP-dependent protein kinase 2. Those nitrotyrosyl-proteins participate in neurotransmission, cellular immunity, and cellular structure and mobility.

[1]  T. Hökfelt,et al.  Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Desiderio,et al.  The human pituitary proteome: the characterization of differentially expressed proteins in an adenoma compared to a control. , 2003, Cellular and molecular biology.

[3]  B. Scheithauer,et al.  Nitric oxide synthase in the human pituitary gland. , 1995, The American journal of pathology.

[4]  Role of nitric oxide in control of prolactin release by the adenohypophysis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Matalon,et al.  Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. , 1994, The Journal of clinical investigation.

[6]  A. Scaloni,et al.  Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. , 2005, Mass spectrometry reviews.

[7]  Xianquan Zhan,et al.  Spot volume vs. amount of protein loaded onto a gel: A detailed, statistical comparison of two gel electrophoresis systems , 2003, Electrophoresis.

[8]  P. Sessarego,et al.  Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly. , 1997, Neuroendocrinology.

[9]  M. Tena-Sempere,et al.  Nitric Oxide Stimulates Growth Hormone Secretion in vitro through a Calcium- and Cyclic Guanosine Monophosphate-Independent Mechanism , 1999, Hormone Research in Paediatrics.

[10]  M. Giusti,et al.  Nitric oxide biphasically modulates GH secretion in cultured cells of GH-secreting human pituitary adenomas. , 2000, Minerva endocrinologica.

[11]  S. Gross,et al.  S-Nitrosylation Is Emerging as a Specific and Fundamental Posttranslational Protein Modification: Head-to-Head Comparison with O-Phosphorylation , 2001, Science's STKE.

[12]  H. Vankelecom,et al.  Inducible Nitric Oxide Synthase in the Anterior Pituitary Gland: Induction by Interferon-γ in a Subpopulation of Folliculostellate Cells and in an Unidentifiable Population of Non-hormone-secreting Cells , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  M. Miyagi,et al.  Evidence That Light Modulates Protein Nitration in Rat Retina * , 2002, Molecular & Cellular Proteomics.

[14]  E. Sheta,et al.  Proteomic Analysis of S-Nitrosylated Proteins in Mesangial Cells * , 2003, Molecular & Cellular Proteomics.

[15]  J. Beckman Nitric oxide and peroxynitrite , 1993 .

[16]  B. Halliwell,et al.  Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. , 1999, Free radical research.

[17]  S. Lightman,et al.  Neuronal nitric oxide synthase gene expression in human pituitary tumours: a possible association with somatotroph adenomas and growth hormone‐releasing hormone gene expression , 1998, Clinical endocrinology.

[18]  M. Lauritzen,et al.  Nitric oxide synthase activity in human pituitary adenomas , 2002, Acta neurologica Scandinavica.

[19]  G. Childs,et al.  Control of gonadotropin secretion by follicle-stimulating hormone-releasing factor, luteinizing hormone-releasing hormone, and leptin. , 2001, Archives of medical research.

[20]  W. Riedel Role of nitric oxide in the control of the hypothalamic-pituitary-adrenocortical axis , 2000, Zeitschrift für Rheumatologie.

[21]  D. Desiderio,et al.  Proteomics analysis of growth hormone isoforms in the human pituitary , 2005, Proteomics.

[22]  Y. Wada,et al.  Decomposition of protein nitrosothiolsin matrix-assisted laser desorption/ionization and electrospray ionization mass spectrometry. , 2003, Journal of mass spectrometry : JMS.

[23]  S. Mccann,et al.  The role of nitric oxide (NO) in control of LHRH release that mediates gonadotropin release and sexual behavior. , 2003, Current pharmaceutical design.

[24]  P. Lähdesmäki,et al.  A peptide containing aspartic acid, glutamic acid and serine in calf brain synaptic vesicles. , 1977, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry.

[25]  M. Vacca,et al.  A possible role for nitric oxide but not for prostaglandin E2 in basal and interleukin-1-beta-induced PRL release in vitro. , 1995, Life sciences.

[26]  J. Schwartz,et al.  Intercellular communication in the anterior pituitary. , 2000, Endocrine reviews.

[27]  M. Kimura,et al.  The Mechanism of Action of Cytokines to Control the Release of Hypothalamic and Pituitary Hormones in Infection , 2000, Annals of the New York Academy of Sciences.

[28]  M. Tena-Sempere,et al.  Effects of Systemic Blockade of Nitric Oxide Synthases on Pulsatile LH, Prolactin, and GH Secretion in Adult Male Rats , 2001, Hormone Research in Paediatrics.

[29]  S. Gygi,et al.  Proteomics: the move to mixtures. , 2001, Journal of mass spectrometry : JMS.

[30]  D. Desiderio,et al.  A reference map of a human pituitary adenoma proteome , 2003, Proteomics.

[31]  M. Giusti,et al.  Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy , 2002, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[32]  Santiago Lamas,et al.  S-nitrosylation: a potential new paradigm in signal transduction. , 2004, Cardiovascular research.